Notice of Proposals to Engage in Permissible Nonbanking Activities or to Acquire Companies that are Engaged in Permissible Nonbanking Activities, 48286 [E7-16678]
Download as PDF
<![CDATA[
48286
Federal Register / Vol. 72, No. 163 / Thursday, August 23, 2007 / Notices
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
Web site at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 17,
2007.
A. Federal Reserve Bank of Chicago
(Burl Thornton, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414.
1. Fox River Financial Corporation,
Burlington, Wisconsin; to become a
bank holding company by acquiring 100
percent of the voting shares of Fox River
State Bank, Burlington, Wisconsin.
Board of Governors of the Federal Reserve
System, August 20, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E7–16680 Filed 8–22–07; 8:45 am]
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center Web site at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than September 7, 2007.
A. Federal Reserve Bank of San
Francisco (Tracy Basinger, Director,
Regional and Community Bank Group)
101 Market Street, San Francisco,
California 94105-1579:
1. Mitsubishi UFJ Financial Group,
Inc., and The Bank of Tokyo–Mitsubishi
UFJ, Ltd., both of Tokyo, Japan; to
acquire up to 12 percent of the voting
shares of Visa, Inc., San Francisco,
California, and thereby indirectly
engage in the operation of electronic
funds transfer systems; the operation of
authorization, clearing, and settlement
systems; and data processing, pursuant
to section 225.28(b)(14) of Regulation Y.
Board of Governors of the Federal Reserve
System, August 20, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E7–16678 Filed 8–22–07; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FEDERAL RESERVE SYSTEM
National Institutes of Health
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
ebenthall on PRODPC61 with NOTICES
BILLING CODE 6210–01–S
Government-Owned Inventions;
Availability for Licensing
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
VerDate Aug<31>2005
15:04 Aug 22, 2007
Jkt 211001
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Methods for Prevention and Treatment
of Polyomavirus Infection or
Reactivation
Description of Technology: Available
for licensing and commercial
development are methods of using
Tranilast [N-(3’,4’dimethoxycinnamoyl)anthranilic acid]
in the prevention and treatment of
human polyomavirus infection.
Treatment with Tranilast decreases viral
protein expression for two human
polyomavirus species, JC virus (JCV)
and BK virus (BKV). Furthermore, the
increase in JCV/BKV protein production
observed upon the addition of TGF-b
could also be effectively abolished by
Tranilast co-treatment. This is of
relevance because TGF-b has previously
been demonstrated to increase during
immunosuppressive conditions,
including HIV infection and kidney
transplantation.
JCV is responsible for demyelization
of the central nervous system, which is
observed in cases of progressive
multifocal leukoencephalopathy (PML).
PML is most frequently seen in patients
with HIV/AIDS, but is also a
contributing factor in fatalities in
patients with leukemia, lymphoma, and
connective tissue diseases, in addition
to individuals receiving
immunosuppressive therapy for
autoimmune disorders or prevention of
transplant rejection. BKV is associated
with serious clinical syndromes such as
viruria and viremia, ureteral ulceration
and stenosis, and hemorrhagic cystitis
and has a causative role in
polyomavirus-associated nephrophathy
in as many as 10% of all renal
transplant recipients. Currently, there
are no effective antiviral agents
available to treat these opportunistic
infections. In all observed cases,
activation of either JCV or BKV in
immunosuppressed patients has
resulted in fatalities.
Applications: Use in treatment and
prevention of polyomavirus infection in
immunocompromised patients. Specific
target is the prevention of PML in
treatment therapies for MS patients.
Development Status: In vitro data is
currently available and inventors are
actively developing the technology.
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 72, Number 163 (Thursday, August 23, 2007)]
[Notices]
[Page 48286]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-16678]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Notice of Proposals to Engage in Permissible Nonbanking
Activities or to Acquire Companies that are Engaged in Permissible
Nonbanking Activities
The companies listed in this notice have given notice under section
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and
Regulation Y (12 CFR Part 225) to engage de novo, or to acquire or
control voting securities or assets of a company, including the
companies listed below, that engages either directly or through a
subsidiary or other company, in a nonbanking activity that is listed in
Sec. [thinsp]225.28 of Regulation Y (12 CFR 225.28) or that the Board
has determined by Order to be closely related to banking and
permissible for bank holding companies. Unless otherwise noted, these
activities will be conducted throughout the United States.
Each notice is available for inspection at the Federal Reserve Bank
indicated. The notice also will be available for inspection at the
offices of the Board of Governors. Interested persons may express their
views in writing on the question whether the proposal complies with the
standards of section 4 of the BHC Act. Additional information on all
bank holding companies may be obtained from the National Information
Center Web site at www.ffiec.gov/nic/.
Unless otherwise noted, comments regarding the applications must be
received at the Reserve Bank indicated or the offices of the Board of
Governors not later than September 7, 2007.
A. Federal Reserve Bank of San Francisco (Tracy Basinger, Director,
Regional and Community Bank Group) 101 Market Street, San Francisco,
California 94105-1579:
1. Mitsubishi UFJ Financial Group, Inc., and The Bank of Tokyo-
Mitsubishi UFJ, Ltd., both of Tokyo, Japan; to acquire up to 12 percent
of the voting shares of Visa, Inc., San Francisco, California, and
thereby indirectly engage in the operation of electronic funds transfer
systems; the operation of authorization, clearing, and settlement
systems; and data processing, pursuant to section 225.28(b)(14) of
Regulation Y.
Board of Governors of the Federal Reserve System, August 20,
2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E7-16678 Filed 8-22-07; 8:45 am]
BILLING CODE 6210-01-S
